Hepatitis Research and Treatment / 2012 / Article / Tab 3

Clinical Study

Prevalence of Occult Hepatitis C Virus in Egyptian Patients with Chronic Lymphoproliferative Disorders

Table 3

Correlation between clinical and laboratory data in HCV positive and OCI positive LPD patients versus HCV and OCI negative LPD patients.

ParameterLPD patients
HCV positiveOCI positiveHCV and OCI negative
value value value

Age 0.0910.5280.0820.5710.0180.9
Hepatomegaly0.0600.2670.0630.2570.1610.244
Splenomegaly0.0920.5260.0890.5380.0950.514
Sex 0.0220.3990.0960.1720.01710.234
Hb (gm%)0.3230.0370.0860.5520.0920.525
Platelets  mm³0.4370.0400.3160.0130.0650.653
TLC/mm³0.0740.6080.0180.4130.0000.999
AST0.0220.3980.4460.0530.0480.742
ALT0.2210.0440.0290.1100.2500.08
Bilirubin (T)0.0590.6820.5180.0210.2360.098

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.